Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Revenues, net:    
Product $ 2,165,500 $ 917,929
Recurring 962,134 1,010,672
Total Net Revenue 3,127,634 1,928,601
Product 1,429,546 600,809
Recurring 266,163 289,909
Total Cost of Sales 1,695,709 890,718
Gross Profit 1,431,925 1,037,883
Operating Expenses:    
Research and development 302,142 230,564
Selling, general and administrative 1,460,593 1,431,781
Depreciation and amortization 64,118 72,598
Total Operating Expense 1,826,853 1,734,943
Loss from Operations (394,928) (697,060)
Interest expense, net (16,638) (31,764)
Total Other Income (Expense) (16,638) (31,764)
Loss Before Provision for Income Taxes (411,566) (728,824)
Provision for Income Taxes 280   
Net Loss (411,846) (728,824)
Accretion of preferred dividends and discount (172,897) (190,753)
Net loss attributable to common stockholders $ (584,743) $ (919,577)
Net income (loss) per common share:    
Income (loss) per common share - basic $ 0.00 $ (0.01)
Income (loss) per common share - diluted $ 0.00 $ (0.01)
Weighted Average Common Shares Outstanding - basic 108,103,001 104,351,326
Weighted Average Common Shares Outstanding - diluted 109,522,960 106,457,737